NWPF

News ArchivesRead News

Parkinson's disease clue may lie just under the skin

Tuesday October 08, 2013

Catharine Paddock

Medical News Today - By discovering that a nervous system protein tends to accumulate at a higher level just under the skin in patients with Parkinson's disease, researchers believe they may have revealed an important clue to diagnosing Parkinson's disease.
Despite being the most frequently occurring neurodegenerative disease in the US, where it affects over 1 million people, Parkinson's disease is difficult to diagnose: there are no standard clinical tests.

This means the disease is often diagnosed only when symptoms like tremors and rigidity emerge, which is well after many brain cells have been destroyed.

Now a new study, published in a recent online issue of the journal Neurology, could help to change that.

Researchers from Beth Israel Deaconess Medical Center (BIDMC), a teaching hospital of Harvard Medical School, found that elevated levels of a nervous system protein called alpha-synuclein can be detected in the skin of people with Parkinson's disease.

They suggest the protein could serve as a biomarker of the disease, helping to spot it before symptoms emerge, when it is hard to detect with current methods.

Senior author Roy Freeman, professor of Neurology at Harvard Medical School and director of the Autonomic and Peripheral Nerve Laboratory at BIDMC, says even experts are often wrong in diagnosing Parkinson's disease:

"A reliable biomarker could help doctors in more accurately diagnosing Parkinson's disease at an earlier stage and thereby offer patients therapies before the disease has progressed."

Main component of abnormal protein clumps in brain cells

Alpha-synuclein occurs throughout the nervous system, and although we do not know much about what it does, scientists have found it is the main component of the abnormal clumps of protein or Lewy bodies, that form inside the brain cells of people with Parkinson's disease. There is also growing evidence to suggest the protein plays a key role in the development of the disease.

Prof. Freeman says:

"Alpha-synuclein deposition occurs early in the course of Parkinson's disease and precedes the onset of clinical symptoms."
Signs of the protein accumulating around nerves in the skin

The researchers had a hunch that they might find earlier signs of Parkinson's by looking at the autonomic nervous system in the skin, and at alpha-synuclein, in particular.

There is already a view that symptoms connected to the autonomic nervous system, such as changes in temperature and blood pressure regulation, and bowel function, may precede the motor system symptoms seen in people with Parkinson's.

Autonomic nervous system changes also occur in the skin, such as excessive or diminished sweating, changes in skin color and temperature. These symptoms occur in nearly two-thirds of patients with Parkinson's disease (PD), says Prof. Freeman.

"The skin can provide an accessible window to the nervous system and based on these clinical observations, we decided to test whether examination of the nerves in a skin biopsy could be used to identify a PD biomarker," he adds.
Higher levels of alpha-synuclein in skin structures of Parkinson's patients

They took their ideas into a study of 20 patients with Parkinson's disease and 14 controls matched for age and gender.

The participants underwent exams and tests of the autonomic nervous system. To measure alpha-synuclein levels, and density of nerve fibers, the participants had skin biopsies on the leg.

The researchers found their hunch was right: the Parkinson's patients had higher levels of alpha-synuclein in the skin nerves supplying the sweat glands and the pilomotor muscles (the ones that produce goose bumps).

They found higher levels of alpha-synuclein in the autonomic nerves of the skin were linked to more advanced Parkinson's symptoms and worse functioning of the autonomic nervous system.

Freeman says there is a strong and unmet need for a biomarker for Parkinson's disease, and:

"Alpha-synuclein deposition within the skin has the potential to provide a safe, accessible and repeatable biomarker."

The researchers now plan to find out if the protein accumulates in the skin nerves of people at risk for Parkinson's disease, and also if testing for it can distinguish Parkinson's from other neurodegenerative diseases.

Earlier this year, researchers at the Mayo Clinic in the US proposed a saliva test for Parkinson's disease.

Paddock, C. (8 Oct 2013). Medical News Today. Parkinson's disease clue may lie just under the skin. www.medicalnewstoday.com.

Recent News

May 20 - Book Review: Aging in the Key of Humor
May 19 - Press Release: The Michael J. Fox Foundation for Parkinson's Research Joins Multinational Critical Path for Parkinson's Consortium
May 19 - Congress reaches deal to overhaul chemical regulation
May 16 - Lifestyle: Why Parkinson's disease won't stop me rowing across the Pacific
May 16 - Many biomarkers for PD fail to inform on progression
May 10 - Parkinson's Cell Transplant Shows Good Reinnervation at 24 Years
May 7 - Growing art installation gathers stories of living with Parkinson's
May 5 - New technique can provide better cell transplants against Parkinson's disease
May 2 - What's Good For The Heart Is Good For The Brain
Apr 29 - Press Release: FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease
Apr 28 - Dopamine-making neurons can be chemically controlled in animal model of Parkinson's
Apr 25 - Lifestyle: Dating with Disease
Apr 25 - Scientific breakthrough in fight against Parkinson's and Alzheimer's
Apr 20 - Breakthrough Parkinson's disease blood test
Apr 15 - Living with Parkinson's
Apr 12 - Tissue biomarker for dementia with Lewy bodies and Parkinson’s disease
Apr 11 - Yoga for Every Body: Experts say yoga can ease pain and improve mobility for people with neurologic conditions
Apr 9 - Commonly prescribed Parkinson's drugs up risk of compulsive gambling, shopping, binge eating, hypersexuality
Apr 7 - Pfizer and IBM Launch Innovative Research Project to Transform Parkinson's Disease Care
Apr 7 - Parkinson's Drug Highly Effective for Resistant Depression